Lormetazepam

DRUG4 trials

Sponsors

Sanofi, Claudia Spies, Hannover Medical School

Conditions

Anxiety DisordersDementiaDepressionPsychosomatic DisordersSchizophreniaSedation in Intensive Care Unit PatientsSleep Initiation and Maintenance Disorders

Phase 3

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

CompletedNCT00679900

SanofiSleep Initiation and Maintenance Disorders

Start: 2008-04-30End: 2009-03-31Updated: 2010-11-30

Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

TerminatedNCT00788515

SanofiSleep Initiation and Maintenance Disorders

Start: 2008-11-30End: 2009-01-31Updated: 2009-08-28

Pharmacovigilance in Gerontopsychiatric Patients

TerminatedNCT02374567

Hannover Medical SchoolAnxiety Disorders, Dementia, Depression +2

Start: 2015-01-31End: 2017-06-28Updated: 2018-02-28

Phase 4

Comparison of Lormetazepam and Midazolam Used as Sedatives for Patients That Require Intensive Care

CompletedNCT02022592

Claudia SpiesSedation in Intensive Care Unit Patients

Start: 2014-07-17End: 2020-03-12Updated: 2022-04-13